The below table shows the top pharma stocks in India based on the highest market capitalization.
Pharma Stock List | Market Cap (Cr) | Closing Price (₹) |
Sun Pharmaceutical Industries Ltd | 4,67,558.41 | 1,948.70 |
Cipla Ltd | 1,35,064.40 | 1,672.50 |
Torrent Pharmaceuticals Ltd | 1,17,867.01 | 3,482.60 |
Dr Reddy’s Laboratories Ltd | 1,12,448.36 | 6,749.90 |
Zydus Lifesciences Ltd | 1,08,265.75 | 1,075.95 |
Mankind Pharma Ltd | 1,03,846.96 | 2,592.00 |
Lupin Ltd | 1,01,195.39 | 2,218.50 |
Aurobindo Pharma Ltd | 87,779.45 | 1,511.35 |
Alkem Laboratories Ltd | 73,946.17 | 6,184.60 |
Abbott India Ltd | 62,200.21 | 29,271.65 |
When it comes to investment, we tend to look for stocks that will stay relevant and perform well for an extended period. Pharmaceutical companies are stocks whose markets will always be relevant.
So this article is an effort to bring out the top pharma companies in India that have performed well in the past and look promising in the future.
You may find the analyzed lists of various factors in the article below. Keep reading to get an idea about the share market’s best pharma stocks.
Content:
- Best Pharma Stocks – 1Y Return
- Top pharma stocks in India – 1M Return
- Best Pharma Stocks in India – Daily Volume
- Best Pharma Stocks – PE Ratio
- Introduction to The Best Healthcare Stocks in India
Best Pharma Stocks
The below table shows the best pharma stocks based on 1 Year return.
Pharma Stocks | Market Cap (Cr) | Closing Price (₹) | 1 Year Return (%) |
Wockhardt Ltd | 15,123.88 | 985.85 | 324.11 |
Wanbury Ltd | 921.36 | 281.37 | 323.75 |
Neuland Laboratories Ltd | 16,410.07 | 12,790.50 | 239.8 |
Bacil Pharma Ltd | 16.66 | 28.28 | 227.69 |
Coral Laboratories Ltd | 318.5 | 891.5 | 210.9 |
Gujarat Terce Laboratories Ltd | 55.26 | 74.47 | 193.65 |
Bharat Parenterals Ltd | 1,050.21 | 1,609.65 | 191.13 |
SMS Pharmaceuticals Ltd | 2,972.98 | 351.2 | 187.28 |
Gujarat Themis Biosyn Ltd | 4,016.46 | 368.6 | 186.11 |
Gennex Laboratories Ltd | 537.23 | 23.62 | 185.96 |
Top Pharma Stocks in India
The below list has been curated upon the 1 Month return among the top pharma stocks in India.
Pharma Stocks | Market Cap (Cr) | Closing Price (₹) | 1 Month Return (%) |
Bacil Pharma Ltd | 16.66 | 28.28 | 58.1 |
Zenith Drugs Ltd | 242.48 | 141.4 | 42.15 |
Norris Medicines Ltd | 17.76 | 17.76 | 35.64 |
Gujarat Terce Laboratories Ltd | 55.26 | 74.47 | 34.29 |
Marksans Pharma Ltd | 13,846.87 | 305.56 | 33.17 |
Medicamen Biotech Ltd | 733.83 | 580.05 | 32.38 |
Concord Biotech Ltd | 21,423.31 | 2,047.80 | 32.16 |
Ami Organics Ltd | 7,014.16 | 1,713.80 | 32.16 |
Jubilant Pharmova Ltd | 18,522.29 | 1,169.70 | 30.85 |
Saroja Pharma Industries India Ltd | 23.42 | 58.25 | 26.91 |
Best Pharma Stocks in India – Daily Volume
The table below shows the best pharma stocks in India based on the highest volume.
Pharma Stocks | Market Cap (Cr) | Closing Price (₹) | Highest Volume |
SeQuent Scientific Ltd | 5,413.96 | 217.28 | 59058970 |
Granules India Ltd | 13,478.12 | 556.1 | 9899590 |
Syncom Formulations (India) Ltd | 2,005.96 | 21.97 | 9492631 |
Morepen Laboratories Ltd | 4,756.79 | 86.81 | 5517213 |
Piramal Pharma Ltd | 29,437.69 | 223.1 | 4406449 |
Laurus Labs Ltd | 25,043.95 | 464.5 | 4168385 |
Cipla Ltd | 1,35,064.40 | 1,672.50 | 3866952 |
Sun Pharmaceutical Industries Ltd | 4,67,558.41 | 1,948.70 | 3809008 |
Alpa Laboratories Ltd | 277.78 | 132.02 | 3297890 |
Zydus Lifesciences Ltd | 1,08,265.75 | 1,075.95 | 2797238 |
Learn more about dividends and dividend payouts by clicking here; also, find out about the top dividend-paying companies in general.
Expanding our list of top pharma companies in India, we have also made a list of debt-free pharma stocks.
Read ahead to know more about it.
Best Pharma Stocks – PE Ratio
The table below shows the best pharma stocks based on PE Ratio.
Pharma Stocks | Market Cap (Cr) | Closing Price (₹) | PE Ratio |
Ind Swift Ltd | 124.15 | 22.92 | 3.24 |
Remedium Lifecare Ltd | 358.44 | 8.89 | 3.86 |
Chemo Pharma Laboratories Ltd | 10.35 | 69.01 | 9.17 |
Transchem Ltd | 49.91 | 40.78 | 10.14 |
Desh Rakshak Aushdhalaya Ltd | 4.99 | 11.24 | 10.41 |
Albert David Ltd | 836.96 | 1,466.50 | 11.95 |
IND Swift Laboratories Ltd | 776.16 | 131.36 | 13.85 |
Lincoln Pharmaceuticals Ltd | 1,360.82 | 679.4 | 14.15 |
Venus Remedies Ltd | 450.4 | 336.95 | 14.66 |
Alpa Laboratories Ltd | 277.78 | 132.02 | 15.03 |
Introduction to The Best Healthcare Stocks in India
Best Pharma Stocks – 1Y Return
Wockhardt Ltd
The Market Cap of Wockhardt Ltd is Rs. 15,123.88 crores. The stock’s monthly return is -5.06%. Its one-year return is 324.11%. The stock is 11.35% away from its 52-week high.
Wockhardt is a leading research-driven global enterprise in pharmaceuticals, biotechnology, and healthcare services. With a strong commitment to innovation and ethical practices, the company leverages its extensive R&D capabilities and international presence to address unmet medical needs, ensuring quality and transparency in its operations.
Wanbury Ltd
The Market Cap of Wanbury Ltd is Rs. 921.36 crores. The stock’s monthly return is 12.74%. Its one-year return is 323.75%. The stock is 3.14% away from its 52-week high.
Wanbury Limited is a rapidly growing Indian pharmaceutical company with a strong focus on Active Pharmaceutical Ingredients (APIs) and branded formulations. Renowned for its extensive product range, Wanbury exports to numerous countries, emphasizing quality and innovation while catering to various therapeutic areas in the healthcare sector.
Neuland Laboratories Ltd
The Market Cap of Neuland Laboratories Ltd is Rs. 16,410.07 crores. The stock’s monthly return is 2.38%. Its one-year return is 239.8%. The stock is 6.56% away from its 52-week high.
Neuland Laboratories Ltd is a leading global Contract Development and Manufacturing Organization (CDMO) specializing in complex active pharmaceutical ingredients (APIs). Committed to excellence and sustainability, the company supports biotech and pharmaceutical partners through every stage of product development, from early design to commercial manufacturing, enhancing healthcare worldwide.
Top Pharma Stocks In India – 1M Return
Bacil Pharma Ltd
The Market Cap of Bacil Pharma Ltd is Rs. 16.66 crores. The stock’s monthly return is 58.1%. Its one-year return is 227.69%. The stock is 3.29% away from its 52-week high.
Bacil Pharma is a prominent pharmaceutical company based in Mumbai, specializing in the manufacturing, exporting, and retailing of a diverse range of products, including anti-anxiety medications and herbal formulations. With over 35 years of experience, it is committed to delivering quality and value to its customers.
Zenith Drugs Ltd
The Market Cap of Zenith Drugs Ltd is Rs. 242.48 crores. The stock’s monthly return is 42.15%. Its one-year return is 34.47%. The stock is 9.19% away from its 52-week high.
Zenith Drugs Limited is a dedicated pharmaceutical manufacturer focused on delivering high-quality, affordable medicines. Founded on principles of care and innovation, the company specializes in various formulations, maintaining stringent quality standards while expanding its market presence through advanced technology and a commitment to customer satisfaction.
Norris Medicines Ltd
The Market Cap of Norris Medicines Ltd is Rs. 17.76 crores. The stock’s monthly return is 35.64%. Its one-year return is 51.79%. The stock is 54.9% away from its 52-week high.
Norris Medicines Ltd is a prominent Indian pharmaceutical manufacturer specializing in a wide range of formulations, including non-sterile and sterile dosages. With over two decades of experience, the company is dedicated to maintaining high-quality standards and expanding its presence in both domestic and international markets.
Best Healthcare Stocks – Highest Volume
SeQuent Scientific Ltd
The Market Cap of SeQuent Scientific Ltd is Rs. 5,413.96 crores. The stock’s monthly return is 15.35%. Its one-year return is 132.63%. The stock is 3.41% away from its 52-week high.
SeQuent is a pioneering company in the animal health sector, specializing in active pharmaceutical ingredients and formulations. Established in 2002, it focuses on enhancing global economic progress and social well-being, leveraging its expertise to make a meaningful impact in the industry with a strong international presence.
Granules India Ltd
The Market Cap of Granules India Ltd is Rs. 13,478.12 crores. The stock’s monthly return is -20.51%. Its one-year return is 59%. The stock is 29.65% away from its 52-week high.
Granules India Limited is a high-growth pharmaceutical manufacturer dedicated to translating science and technology into high-quality products. With a focus on vertical integration and customer centricity, the company emphasizes research and development to create safe, effective, and affordable medicines for global markets.
Syncom Formulations (India) Ltd
The Market Cap of Syncom Formulations (India) Ltd is Rs. 2,005.96 crores. The stock’s monthly return is 1.23%. Its one-year return is 158.47%. The stock is 26.99% away from its 52-week high.
Syncom Formulations (India) Ltd is a leading pharmaceutical company specializing in the development and manufacturing of a diverse range of formulations. Committed to quality and innovation, it aims to deliver effective healthcare solutions while adhering to stringent regulatory standards and fostering strong partnerships in the global market.
Best Healthcare Stocks – PE Ratio
Ind Swift Ltd
The Market Cap of Ind Swift Ltd is Rs. 124.15 crores. The stock’s monthly return is -5.71%. Its one-year return is 12.91%. The stock is 36.13% away from its 52-week high.
Indswift Limited is a prominent player in the pharmaceutical industry, dedicated to manufacturing and distributing a wide range of high-quality medications. With a focus on innovation and customer satisfaction, the company strives to enhance global healthcare standards while maintaining a commitment to ethical practices and sustainability.
Remedium Lifecare Ltd
The Market Cap of Remedium Lifecare Ltd is Rs. 358.44 crores. The stock’s monthly return is 0.45%. Its one-year return is -75.43%. The stock is 330.26% away from its 52-week high.
Remedium Lifecare Limited is a dynamic pharmaceutical company focused on trading active pharmaceutical ingredients and intermediates. Committed to quality and innovation, it aims to enhance healthcare through strong customer partnerships. With a dedication to ethical practices, Remedium strives to positively impact society while meeting global industry standards.
Chemo Pharma Laboratories Ltd
The Market Cap of Chemo Pharma Laboratories Ltd is Rs. 10.35 crores. The stock’s monthly return is -8.79%. Its one-year return is 143.42%. The stock is 26.07% away from its 52-week high.
Chemo Pharma Laboratories Limited has been a longstanding player in the pharmaceutical industry, originally established in 1942. Facing increased competition, the company is now focusing on diversification and plans to acquire a promising distressed company in the power and chemicals sector for future growth.
Here are some of the Best Stock Research Articles listed based on Top Sectors (Industries), Market Cap, and Fundamental Analysis Factors:
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.